| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:02 UTC |
|---|
| HMDB ID | HMDB0015599 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Enoximone |
|---|
| Description | Enoximone, also known as perfan, belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group. Enoximone is a drug which is used for the treatment of congestive heart failure. Based on a literature review a significant number of articles have been published on Enoximone. |
|---|
| Structure | CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1 InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16) |
|---|
| Synonyms | | Value | Source |
|---|
| Perfan | Kegg | | Aventis brand OF enoximone | HMDB | | Enoximone aventis brand | HMDB | | Fenoximone | HMDB | | Enoximone myogen brand | HMDB | | Myogen brand OF enoximone | HMDB | | Carinopharm brand OF enoximone | HMDB | | Enoximone carinopharm brand | HMDB |
|
|---|
| Chemical Formula | C12H12N2O2S |
|---|
| Average Molecular Weight | 248.301 |
|---|
| Monoisotopic Molecular Weight | 248.061948328 |
|---|
| IUPAC Name | 4-methyl-5-[4-(methylsulfanyl)benzoyl]-2,3-dihydro-1H-imidazol-2-one |
|---|
| Traditional Name | enoximone |
|---|
| CAS Registry Number | 77671-31-9 |
|---|
| SMILES | CSC1=CC=C(C=C1)C(=O)C1=C(C)NC(=O)N1 |
|---|
| InChI Identifier | InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16) |
|---|
| InChI Key | ZJKNESGOIKRXQY-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Aryl-phenylketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aryl-phenylketone
- Aryl thioether
- Benzoyl
- Thiophenol ether
- Imidazole-4-carbonyl group
- Alkylarylthioether
- Monocyclic benzene moiety
- Benzenoid
- Azole
- Heteroaromatic compound
- Imidazole
- Vinylogous amide
- Urea
- Sulfenyl compound
- Organoheterocyclic compound
- Thioether
- Azacycle
- Organic nitrogen compound
- Organonitrogen compound
- Organosulfur compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 256 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.068 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.15 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.0323 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.07 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2077.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 400.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 153.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 223.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 215.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 583.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 680.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 86.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1176.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 420.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1307.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 384.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 420.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 332.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 339.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 39.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Enoximone,1TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)[NH]2)C=C1 | 2518.7 | Semi standard non polar | 33892256 | | Enoximone,1TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)[NH]2)C=C1 | 2310.2 | Standard non polar | 33892256 | | Enoximone,1TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)[NH]2)C=C1 | 2886.6 | Standard polar | 33892256 | | Enoximone,1TMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C)C=C1 | 2499.2 | Semi standard non polar | 33892256 | | Enoximone,1TMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C)C=C1 | 2235.9 | Standard non polar | 33892256 | | Enoximone,1TMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C)C=C1 | 2828.3 | Standard polar | 33892256 | | Enoximone,2TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)N2[Si](C)(C)C)C=C1 | 2569.3 | Semi standard non polar | 33892256 | | Enoximone,2TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)N2[Si](C)(C)C)C=C1 | 2352.2 | Standard non polar | 33892256 | | Enoximone,2TMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C)C(=O)N2[Si](C)(C)C)C=C1 | 2658.9 | Standard polar | 33892256 | | Enoximone,1TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)[NH]2)C=C1 | 2712.1 | Semi standard non polar | 33892256 | | Enoximone,1TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)[NH]2)C=C1 | 2552.3 | Standard non polar | 33892256 | | Enoximone,1TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)[NH]2)C=C1 | 2949.7 | Standard polar | 33892256 | | Enoximone,1TBDMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2681.6 | Semi standard non polar | 33892256 | | Enoximone,1TBDMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2444.1 | Standard non polar | 33892256 | | Enoximone,1TBDMS,isomer #2 | CSC1=CC=C(C(=O)C2=C(C)[NH]C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2898.9 | Standard polar | 33892256 | | Enoximone,2TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2930.4 | Semi standard non polar | 33892256 | | Enoximone,2TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2768.8 | Standard non polar | 33892256 | | Enoximone,2TBDMS,isomer #1 | CSC1=CC=C(C(=O)C2=C(C)N([Si](C)(C)C(C)(C)C)C(=O)N2[Si](C)(C)C(C)(C)C)C=C1 | 2854.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Enoximone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-4940000000-2c3d1d1ddd2652a0e57c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Enoximone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoximone LC-ESI-qTof , Positive-QTOF | splash10-004i-3910100000-ff2ed6a9d4b5b2530185 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Enoximone , positive-QTOF | splash10-004i-3910100000-ff2ed6a9d4b5b2530185 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 10V, Positive-QTOF | splash10-0002-0090000000-0e4975ce7aaf5ff4fc28 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 20V, Positive-QTOF | splash10-0002-1190000000-df4edb235b0c4a91505e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 40V, Positive-QTOF | splash10-0f7y-9640000000-920c05b460908f787465 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 10V, Negative-QTOF | splash10-0002-4390000000-c4adff3885f495ea4c8a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 20V, Negative-QTOF | splash10-0002-3970000000-c39dc81cb11ea90992ee | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 40V, Negative-QTOF | splash10-0005-9000000000-495a6052f4f3d6d21398 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 10V, Positive-QTOF | splash10-0002-0090000000-8bd98f7a7fc6db23ff0f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 20V, Positive-QTOF | splash10-001i-0690000000-1303c6a9cc10a4120574 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 40V, Positive-QTOF | splash10-0ukc-6900000000-b391e964d41a1cc1220a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 10V, Negative-QTOF | splash10-0002-0090000000-409760192e17bc5104c6 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 20V, Negative-QTOF | splash10-0f6t-9830000000-c2debf31c8846a740a40 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Enoximone 40V, Negative-QTOF | splash10-0006-9600000000-a31795b584b0ae92bcff | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Boldt J, Suttner S: Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone. Expert Opin Pharmacother. 2007 Sep;8(13):2135-47. [PubMed:17714066 ]
- Sandroni C, Cavallaro F, Caricato A, Scapigliati A, Fenici P, Antonelli M: Enoximone in cardiac arrest caused by propranolol: two case reports. Acta Anaesthesiol Scand. 2006 Jul;50(6):759-61. [PubMed:16987374 ]
- van der Maaten JM, de Vries AJ, Rietman GW, Gallandat Huet RC, De Hert SG: Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis. J Cardiothorac Vasc Anesth. 2007 Jun;21(3):357-66. Epub 2006 May 4. [PubMed:17544886 ]
- Schauvliege S, Van den Eede A, Duchateau L, Gasthuys F: Cardiovascular effects of enoximone in isoflurane anaesthetized ponies. Vet Anaesth Analg. 2007 Nov;34(6):416-30. Epub 2007 Aug 13. [PubMed:17696974 ]
|
|---|